Analyzed market size, drivers, and use cases for a niche life sciences firm's new solution via research and expert interviews. Delivered strategic options enabling a prioritized go-to-market plan in a regulated sector.
A life sciences company sought to launch a new solution in a highly regulated market segment. To prioritize this initiative and develop an effective go-to-market strategy, the client needed a clear understanding of market dynamics, size, and growth drivers.
The decision hinged on assessing how regulatory and technological shifts would shape opportunities and identifying the most promising use cases.
Our engagement leveraged a focused, multi-pronged methodology to deliver actionable insights:
Analyzed market size, regulatory events, and emerging technologies to forecast growth potential and timing of key shifts. Developed a preliminary assessment of test use cases and purchasing criteria across customer types.
Identified and conducted qualitative in-depth interviews (some exceeding 3 hours) with industry experts, customers, and distributors to obtain a better picture of the market and stress-test assumptions, refine market drivers, and validate customer decision-making factors.
Integrated findings into a comprehensive evaluation of growth opportunities, pinpointing high-potential use cases and target segments for the client to prioritize. Explored organic and inorganic entry options to optimize market positioning.
A highly niche market, where traditional expert networks struggled to find suitable experts. LNQP's proprietary AI-powered search identified 40% of experts, while the remaining 60% were sourced from five different network providers—demonstrating the value of a multi-pronged sourcing approach for specialized markets.
3-phase analysis enabling a data-driven investment decision with 20% model accuracy.
Sized markets and led target identification for a B2B service provider entering Germany.
Identified €600M in untapped sales potential for a global pharmaceutical CDMO.
